99 related articles for article (PubMed ID: 9514977)
1. Sendai viruses with altered P, V, and W protein expression.
Delenda C; Taylor G; Hausmann S; Garcin D; Kolakofsky D
Virology; 1998 Mar; 242(2):327-37. PubMed ID: 9514977
[TBL] [Abstract][Full Text] [Related]
2. Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis.
Hu CJ; Kato A; Bowman MC; Kiyotani K; Yoshida T; Moyer SA; Nagai Y; Gupta KC
Virology; 1999 Oct; 263(1):195-208. PubMed ID: 10544094
[TBL] [Abstract][Full Text] [Related]
3. Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein.
Delenda C; Hausmann S; Garcin D; Kolakofsky D
Virology; 1997 Feb; 228(1):55-62. PubMed ID: 9024809
[TBL] [Abstract][Full Text] [Related]
4. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.
Kato A; Kiyotani K; Sakai Y; Yoshida T; Nagai Y
EMBO J; 1997 Feb; 16(3):578-87. PubMed ID: 9034340
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
Durbin AP; McAuliffe JM; Collins PL; Murphy BR
Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
[TBL] [Abstract][Full Text] [Related]
6. The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication.
Horikami SM; Smallwood S; Moyer SA
Virology; 1996 Aug; 222(2):383-90. PubMed ID: 8806522
[TBL] [Abstract][Full Text] [Related]
7. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
[TBL] [Abstract][Full Text] [Related]
8. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice.
Tanaka S; Yonemitsu Y; Yoshida K; Okano S; Kondo H; Inoue M; Hasegawa M; Masumoto K; Suita S; Taguchi T; Sueishi K
Gene Ther; 2007 Jul; 14(13):1017-28. PubMed ID: 17460720
[TBL] [Abstract][Full Text] [Related]
9. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function.
Devaux P; Cattaneo R
J Virol; 2004 Nov; 78(21):11632-40. PubMed ID: 15479804
[TBL] [Abstract][Full Text] [Related]
10. De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene.
Touzelet O; Loukili N; Pelet T; Fairley D; Curran J; Power UF
Virus Res; 2009 Mar; 140(1-2):40-8. PubMed ID: 19084562
[TBL] [Abstract][Full Text] [Related]
11. An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation.
Curran J; Pelet T; Kolakofsky D
Virology; 1994 Aug; 202(2):875-84. PubMed ID: 8030249
[TBL] [Abstract][Full Text] [Related]
12. Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis.
Grogan CC; Moyer SA
Virology; 2001 Sep; 288(1):96-108. PubMed ID: 11543662
[TBL] [Abstract][Full Text] [Related]
13. Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis.
Kurotani A; Kiyotani K; Kato A; Shioda T; Sakai Y; Mizumoto K; Yoshida T; Nagai Y
Genes Cells; 1998 Feb; 3(2):111-24. PubMed ID: 9605405
[TBL] [Abstract][Full Text] [Related]
14. A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture.
Garcin D; Itoh M; Kolakofsky D
Virology; 1997 Nov; 238(2):424-31. PubMed ID: 9400614
[TBL] [Abstract][Full Text] [Related]
15. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
[TBL] [Abstract][Full Text] [Related]
16. Presence of a truncated form of the Sendai virus P protein in a long-term persistent infection: implications for the maintenance of the persistent state.
Garcin D; De Melo M; Roux L; Kolakofsky D; Curran J
Virology; 1994 May; 201(1):19-25. PubMed ID: 8178486
[TBL] [Abstract][Full Text] [Related]
17. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis.
Kato A; Kiyotani K; Sakai Y; Yoshida T; Shioda T; Nagai Y
J Virol; 1997 Oct; 71(10):7266-72. PubMed ID: 9311801
[TBL] [Abstract][Full Text] [Related]
18. Mutations in domain V of the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo.
Cortese CK; Feller JA; Moyer SA
Virology; 2000 Nov; 277(2):387-96. PubMed ID: 11080486
[TBL] [Abstract][Full Text] [Related]
19. Variants of the paramyxovirus Simian virus 5 with accelerated or delayed viral gene expression activate proinflammatory cytokine synthesis.
Young VA; Dillon PJ; Parks GD
Virology; 2006 Jun; 350(1):90-102. PubMed ID: 16480754
[TBL] [Abstract][Full Text] [Related]
20. V and C proteins of measles virus function as virulence factors in vivo.
Patterson JB; Thomas D; Lewicki H; Billeter MA; Oldstone MB
Virology; 2000 Feb; 267(1):80-9. PubMed ID: 10648185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
